Business Context and Reporting Period
This Form 8-K Current Report was filed by LeMaitre Vascular, Inc. on August 4, 2021. The filing addresses the full exercise of an underwriters' option to purchase additional shares of common stock pursuant to an underwriting agreement dated July 13, 2021.
Key Financial Metrics
The filing details a specific equity transaction rather than providing comprehensive financial statements.
- Shares Issued: 150,000 additional shares of Common Stock.
- Offering Price: $54.50 per share.
- Total Proceeds: $8,175,000 (calculated as 150,000 shares x $54.50).
- Underwriters: Jefferies LLC and Stifel, Nicolaus & Company, Incorporated.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics beyond the proceeds from this specific transaction.
Material Changes
The material change reported is the increase in outstanding common stock due to the full exercise of the underwriters' option. This follows the initial sale of 1,000,000 shares under the same agreement.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a factual disclosure of a completed securities transaction.
Key Facts for Investor Verification
- Verify the total number of shares outstanding post-transaction (initial 1,000,000 plus 150,000 option shares).
- Confirm the use of proceeds from the $8,175,000 raised in this tranche.
- Review the original underwriting agreement dated July 13, 2021, for details on the initial offering terms.